Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trialJong Wook Lee, Yasuo Mori, Jin Seok Kim et al.|The Lancet Haematology|2023Cited by 88
A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile NeutropeniaMoshe E. Gatt, Ora Paltiel, Jacob Strahilevitz et al.|Integrative Cancer Therapies|2015Cited by 18
Meetings and ConferencesBehrouz Mansouri Taleghani, on behalf of the Board of the German Society of Transfusion Medicine and Immunohaematology, Flemming Balstrup et al.|Transfusion Medicine and Hemotherapy|2014Cited by 0